Beth Israel Deaconess Med Center

Boston, Massachusetts 02215

2 studies enrolling now · 10 studies all time

What they study most

Acute Kidney Injury Due to Sepsis, Advanced Renal Cell Carcinoma, Brain Edema, Brain Tumor, HIV-1 Infections, Hidradenitis Suppurativa, Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Primary Immune Thrombocytopenia (ITP), Prostate Cancer

Studies at this site

• Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC — Recruiting now
• CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
• Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) — Completed
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies — Running, not enrolling
• Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa — Running, not enrolling
• Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma — Stopped early
• Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults — Completed
• XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema — Withdrawn before enrolling